Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Vonoprazan

Vonoprazan (TAK-438 free base), a proton pump inhibitor (PPI), is a potent and orally active potassium-competitive acid blocker (P-CAB), with antisecretory activity. Vonoprazan inhibits H+, K+-ATPase activity in porcine gastric microsomes with an IC50 of 19 nM at pH 6.5. Vonoprazan is developed for the research of acid-related diseases, such as gastroesophageal reflux disease and peptic ulcer disease. Vonoprazan can be used for eradication of Helicobacter pylori[1][2][3].

Product Specifications

CAS Number

881681-00-1

Product Name Alternative

TAK-438 (free base)

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

Bacterial; Proton Pump

Type

Reference compound

Related Pathways

Anti-infection; Membrane Transporter/Ion Channel

Field of Research

Endocrinology; Cancer

Assay Protocol

https://www.medchemexpress.com/TAK-438-free-base.html

Purity

99.89

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

O=S(N1C=C(CNC)C=C1C2=CC=CC=C2F)(C3=CC=CN=C3)=O

Molecular Formula

C17H16FN3O2S

Molecular Weight

345.40

Precautions

H302, H315, H319, H335

References & Citations

[1]Arikawa Y, et al. Discovery of a novel pyrrole derivative 1-[5- (2-fluorophenyl) -1- (pyridin-3-ylsulfonyl) -1H-pyrrol-3-yl]-N-methylmethanamine fumarate (TAK-438) as a potassium-competitive acid blocker (P-CAB) . J Med Chem, 2012, 55 (9), 4446-4456.|[2]Hori Y, et al. 1-[5- (2-Fluorophenyl) -1- (pyridin-3-ylsulfonyl) -1H-pyrrol-3-yl]-N-methylmethanamine monofumarate (TAK-438), a novel and potent potassium-competitive acid blocker for the treatment of acid-related diseases. J Pharmacol Exp Ther, 2010, 335 (1), 231-238.|[3]Sugimoto M, et al. Role of Vonoprazan in Helicobacter pylori Eradication Therapy in Japan. Front Pharmacol. 2019 Jan 15;9:1560.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

Launched

Citation 01

Br J Clin Pharmacol. 2019 Jul;85 (7) :1454-1463.|Int J Nanomedicine. 2025 Jun 24:20:8063-8083.|Toxicol Appl Pharmacol. 2024 May:486:116945.|Drug Dev Res. 2022 Dec 9.|Drug Metab Dispos. 2016 Oct;44 (10) :1543-9. |Eur J Med Chem. 2024 Dec 5:279:116842.

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Phenol-13C6
TRC-P318002-250MG 250 mg

Phenol-13C6

Sign In for Pricing
View Details
AP3M1 (NM_012095) Human Recombinant Protein
TP761671 50 µg

AP3M1 (NM_012095) Human Recombinant Protein

Sign In for Pricing
View Details
Elab Fluor® 700 Anti-Human CD5 Antibody[UCHT2]
E-AB-F1041M1-01 20 Tests

Elab Fluor® 700 Anti-Human CD5 Antibody[UCHT2]

Sign In for Pricing
View Details
Elab Fluor® 700 Anti-Human CD5 Antibody[UCHT2]
E-AB-F1041M1-02 100 Tests

Elab Fluor® 700 Anti-Human CD5 Antibody[UCHT2]

Sign In for Pricing
View Details
Elab Fluor® 700 Anti-Human CD5 Antibody[UCHT2]
E-AB-F1041M1-03 2x 100 Tests

Elab Fluor® 700 Anti-Human CD5 Antibody[UCHT2]

Sign In for Pricing
View Details
Tissue Protein Lysate, Ovary: right
CP565697 150 µg

Tissue Protein Lysate, Ovary: right

Sign In for Pricing
View Details